Who is sponsoring NCT03418597?

NCT03418597 is sponsored by Centre Leon Berard.

What drugs are being tested in NCT03418597?

Interventions in NCT03418597: Deep local anesthesia + Virtual reality, Deep local anesthesia alone.

What condition does NCT03418597 study?

NCT03418597 studies Musculoskeletal Cancers.

Is NCT03418597 still recruiting?

NCT03418597 is currently completed. Last updated 23 August 2018.

Last reviewed 2018-08-23 · How we verify

NCT03418597: REVENRI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trial Evaluating Hypnosis Using Virtural Reality vs Standard Pain Management During Musculoskelettal Biopsy

Completed NA Last updated 23 August 2018

What this trial tests

NA trial testing Deep local anesthesia + Virtual reality in Musculoskeletal Cancers in 99 participants. Completed in 16 May 2018.

Timeline

31 January 2018

Primary endpoint
16 May 2018

16 May 2018

Quick facts

Lead sponsor	Centre Leon Berard
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	99
Start date	31 January 2018
Primary completion	16 May 2018
Estimated completion	16 May 2018
Sites	1 location across France

Drugs / interventions tested

Deep local anesthesia + Virtual reality
Deep local anesthesia alone

Conditions studied

Musculoskeletal Cancers — all drugs for Musculoskeletal Cancers →

Sponsor

Centre Leon Berard — full company profile →

Who can join

18 and older, any sex, with Musculoskeletal Cancers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this trial is to evaluate the benefit of the virtual reality technology in the pain management for patients having a radio-guided musculoskeletal biopsy indication

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Leon Berard trials

Trials by the same sponsor.

NCT07499921 — Clinical and BIOgical Analyses of RECtal Tumors · NA · not yet recruiting
NCT07515274 — Evaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Been Treated for Cancer · NA · not yet recruiting
NCT07243483 — Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute My · NA · recruiting
NCT07334990 — Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung Canc · NA · not yet recruiting
NCT07414719 — Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03418597 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Leon Berard
Last refreshed: 23 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03418597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing